Contrast enhanced high resolution MRI of cutaneous melanomas using Gd-DTPA and Gd-DTPA-polylysine: Experimental results

J. Mäurer, Friedrich D Knollmann, C. Veuskens, W. Ebert, H. Bauer, R. Felix

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background/aims: An experimental model for the preclinical evaluation of contrast enhancement patterns in melanoma was developed. Methods: Melanotic and amelanotic tumor cells B16F1 and B16a implanted into murine skin were depicted with magnetic resonance imaging (MRI) at a pixel size of 78 x 78 μm and 1 mm slice thickness. Tumor signal intensities were evaluated in user defined ROIs (regions of interest). Signal intensity changes were determined from signal intensity-time curves. Percent enhancement, slope of the signal intensity curve and percent signal intensity increase were also determined. Percent enhancement was calculated: (SI(enhanced) - SI(plain))/SI(plain) x 100 [SI = signal intensity]. The slope of the signal intensity curve was calculated: (SI(max) - SI(plain))/(SI(plain) x SI(max)) x 100 (%/min). Percent signal intensity increase was calculated: (SI(max) - SI(plain)/SI(plain) x 100. Results: Following i.v. administration of Gd-DTPA and G-DTPA-polylysine, all tumors showed pronounced contrast enhancement. Contrast enhancement and the slope of signal intensity to time curves did not distinguish melanotic from amelanotic melanomas (P > 0.05). Conclusions: The animal model presented is well suited for evaluation of contrast enhancement in melanoma by MRI. Contrast enhancement of melanoma in MRI is comparable with the enhancement seen in other tumors.

Original languageEnglish (US)
Pages (from-to)49-53
Number of pages5
JournalSkin Research and Technology
Volume4
Issue number1
DOIs
StatePublished - Feb 1998
Externally publishedYes

Fingerprint

Gadolinium DTPA
Melanoma
Magnetic Resonance Imaging
Skin
Neoplasms
Amelanotic Melanoma
Pentetic Acid
Polylysine
Theoretical Models
Animal Models
polylysine-(Gd-DTPA)

Keywords

  • Contrast medium
  • Gd-DTPA
  • Gd-DTPA-polylysine
  • High resolution
  • Melanoma
  • MRI

ASJC Scopus subject areas

  • Dermatology

Cite this

Contrast enhanced high resolution MRI of cutaneous melanomas using Gd-DTPA and Gd-DTPA-polylysine : Experimental results. / Mäurer, J.; Knollmann, Friedrich D; Veuskens, C.; Ebert, W.; Bauer, H.; Felix, R.

In: Skin Research and Technology, Vol. 4, No. 1, 02.1998, p. 49-53.

Research output: Contribution to journalArticle

@article{5d018785663444ccadda546758f70234,
title = "Contrast enhanced high resolution MRI of cutaneous melanomas using Gd-DTPA and Gd-DTPA-polylysine: Experimental results",
abstract = "Background/aims: An experimental model for the preclinical evaluation of contrast enhancement patterns in melanoma was developed. Methods: Melanotic and amelanotic tumor cells B16F1 and B16a implanted into murine skin were depicted with magnetic resonance imaging (MRI) at a pixel size of 78 x 78 μm and 1 mm slice thickness. Tumor signal intensities were evaluated in user defined ROIs (regions of interest). Signal intensity changes were determined from signal intensity-time curves. Percent enhancement, slope of the signal intensity curve and percent signal intensity increase were also determined. Percent enhancement was calculated: (SI(enhanced) - SI(plain))/SI(plain) x 100 [SI = signal intensity]. The slope of the signal intensity curve was calculated: (SI(max) - SI(plain))/(SI(plain) x SI(max)) x 100 ({\%}/min). Percent signal intensity increase was calculated: (SI(max) - SI(plain)/SI(plain) x 100. Results: Following i.v. administration of Gd-DTPA and G-DTPA-polylysine, all tumors showed pronounced contrast enhancement. Contrast enhancement and the slope of signal intensity to time curves did not distinguish melanotic from amelanotic melanomas (P > 0.05). Conclusions: The animal model presented is well suited for evaluation of contrast enhancement in melanoma by MRI. Contrast enhancement of melanoma in MRI is comparable with the enhancement seen in other tumors.",
keywords = "Contrast medium, Gd-DTPA, Gd-DTPA-polylysine, High resolution, Melanoma, MRI",
author = "J. M{\"a}urer and Knollmann, {Friedrich D} and C. Veuskens and W. Ebert and H. Bauer and R. Felix",
year = "1998",
month = "2",
doi = "10.1111/j.1600-0846.1998.tb00086.x",
language = "English (US)",
volume = "4",
pages = "49--53",
journal = "Skin Research and Technology",
issn = "0909-752X",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Contrast enhanced high resolution MRI of cutaneous melanomas using Gd-DTPA and Gd-DTPA-polylysine

T2 - Experimental results

AU - Mäurer, J.

AU - Knollmann, Friedrich D

AU - Veuskens, C.

AU - Ebert, W.

AU - Bauer, H.

AU - Felix, R.

PY - 1998/2

Y1 - 1998/2

N2 - Background/aims: An experimental model for the preclinical evaluation of contrast enhancement patterns in melanoma was developed. Methods: Melanotic and amelanotic tumor cells B16F1 and B16a implanted into murine skin were depicted with magnetic resonance imaging (MRI) at a pixel size of 78 x 78 μm and 1 mm slice thickness. Tumor signal intensities were evaluated in user defined ROIs (regions of interest). Signal intensity changes were determined from signal intensity-time curves. Percent enhancement, slope of the signal intensity curve and percent signal intensity increase were also determined. Percent enhancement was calculated: (SI(enhanced) - SI(plain))/SI(plain) x 100 [SI = signal intensity]. The slope of the signal intensity curve was calculated: (SI(max) - SI(plain))/(SI(plain) x SI(max)) x 100 (%/min). Percent signal intensity increase was calculated: (SI(max) - SI(plain)/SI(plain) x 100. Results: Following i.v. administration of Gd-DTPA and G-DTPA-polylysine, all tumors showed pronounced contrast enhancement. Contrast enhancement and the slope of signal intensity to time curves did not distinguish melanotic from amelanotic melanomas (P > 0.05). Conclusions: The animal model presented is well suited for evaluation of contrast enhancement in melanoma by MRI. Contrast enhancement of melanoma in MRI is comparable with the enhancement seen in other tumors.

AB - Background/aims: An experimental model for the preclinical evaluation of contrast enhancement patterns in melanoma was developed. Methods: Melanotic and amelanotic tumor cells B16F1 and B16a implanted into murine skin were depicted with magnetic resonance imaging (MRI) at a pixel size of 78 x 78 μm and 1 mm slice thickness. Tumor signal intensities were evaluated in user defined ROIs (regions of interest). Signal intensity changes were determined from signal intensity-time curves. Percent enhancement, slope of the signal intensity curve and percent signal intensity increase were also determined. Percent enhancement was calculated: (SI(enhanced) - SI(plain))/SI(plain) x 100 [SI = signal intensity]. The slope of the signal intensity curve was calculated: (SI(max) - SI(plain))/(SI(plain) x SI(max)) x 100 (%/min). Percent signal intensity increase was calculated: (SI(max) - SI(plain)/SI(plain) x 100. Results: Following i.v. administration of Gd-DTPA and G-DTPA-polylysine, all tumors showed pronounced contrast enhancement. Contrast enhancement and the slope of signal intensity to time curves did not distinguish melanotic from amelanotic melanomas (P > 0.05). Conclusions: The animal model presented is well suited for evaluation of contrast enhancement in melanoma by MRI. Contrast enhancement of melanoma in MRI is comparable with the enhancement seen in other tumors.

KW - Contrast medium

KW - Gd-DTPA

KW - Gd-DTPA-polylysine

KW - High resolution

KW - Melanoma

KW - MRI

UR - http://www.scopus.com/inward/record.url?scp=0031881521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031881521&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0846.1998.tb00086.x

DO - 10.1111/j.1600-0846.1998.tb00086.x

M3 - Article

AN - SCOPUS:0031881521

VL - 4

SP - 49

EP - 53

JO - Skin Research and Technology

JF - Skin Research and Technology

SN - 0909-752X

IS - 1

ER -